檢索結果 - Christopher Frantz

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin

    Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin 由 CB Cooke, László Krenács, M Stetler-Stevenson, TC Greiner, Mark Raffeld, DW Kingma, Lynne V. Abruzzo, Christopher Frantz, Mozhgan Kaviani, ES Jaffe

    出版 1996
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin

    Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin 由 CB Cooke, L. Krenacs, Maryalice Stetler‐Stevenson, TC Greiner, Mark Raffeld, DW Kingma, Lynne V. Abruzzo, Christopher Frantz, Mozhgan Kaviani, ES Jaffe

    出版 1996
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study

    Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study 由 Wendy B. London, Christopher Frantz, Laura Campbell, Robert C. Seeger, Babette Brumback, Susan L. Cohn, Katherine K. Matthay, Robert P. Castleberry, Lisa Diller

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Outcomes of Children With Intermediate-Risk Neuroblastoma After Treatment Stratified by <i>MYCN</i> Status and Tumor Cell Ploidy

    Outcomes of Children With Intermediate-Risk Neuroblastoma After Treatment Stratified by <i>MYCN</i> Status and Tumor Cell Ploidy 由 Rochelle Bagatell, Pavlina Rumcheva, Wendy B. London, Susan L. Cohn, A. Thomas Look, Garrett M. Brodeur, Christopher Frantz, Vijay Joshi, Paul S. Thorner, Pejaver V. Rao, Robert P. Castleberry, Laura C. Bowman

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    The Vedotin Antibody–Drug Conjugate Payload Drives Platform-Based Nonclinical Safety and Pharmacokinetic Profiles

    The Vedotin Antibody–Drug Conjugate Payload Drives Platform-Based Nonclinical Safety and Pharmacokinetic Profiles 由 Haley D. Neff‐LaFord, Sarah A. Carratt, Christopher M. Carosino, Nancy Everds, Kristen A. Cardinal, Steven Duniho, Melissa M. Schutten, Christopher Frantz, Christina L. Zuch de Zafra, Eric B. Harstad

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate)

    Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate) 由 Szczepan W. Baran, Paul C. Brown, Andreas R. Baudy, Suzanne Fitzpatrick, Christopher Frantz, Aaron Fullerton, Jinping Gan, Rhiannon N. Hardwick, Kathleen M. Hillgren, Anna K. Kopec, Jennifer L. Liras, Donna L. Mendrick, Ryan J. Nagao, William R. Proctor, Diane Ramsden, Alexandre J. S. Ribeiro, David M. Stresser, Kyung E. Sung, Radhakrishna Sura, Kazuhiro Tetsuka, Lindsay Tomlinson, Terry Van Vleet, Matthew P. Wagoner, Qin Wang, Sevim Yildiz Arslan, Gorm Yoder, Jason E. Ekert

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: